Key result
Pediatric patients with healing-stage acute myocarditis had higher ICAM-1 expression on myocardial tissue compared to controls.
Observational (n=11)
Persistent expression of ICAM-1 and VCAM-1 in pediatric myocarditis suggests ongoing immunological myocardial cell damage and may serve as a diagnostic marker.
Answers are grounded in this paper and cite their sources.
ICAM-1 expression may support myocarditis evaluation in children; leaves open validation as a diagnostic biomarker.
BACKGROUND: Both intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been implicated in cardiac allograft rejection. However, there is little information about the relationship between the expression of these adhesion molecules and myocarditis in children. METHODS AND RESULTS: Immunoreactivities of ICAM-1 and VCAM-1 were examined by enzyme immunoassay in 31 biopsy specimens obtained from 11 pediatric patients with biopsy-proven myocarditis or cardiomyopathy. Five of the 11 patients had clear evidence of acute myocarditis. The other 6 had ECG abnormalities identified by mass screening for heart disease, and subsequently had been histologically diagnosed as having non-specific cardiomyopathy. The period between onset of myocarditis or identification of ECG abnormality and immunohistochemical studies was 23 to 60 days and 8 months to 3 years, respectively. Expression of ICAM-1 and VCAM-1 was assessed by counting ICAM-1 and VCAM-1 positive vessels and dividing by the total number of vessels. ICAM-1 was significantly present on 81% (P < 0.01) of myocardial tissue samples in the 5 patients with healing-stage acute myocarditis, and on 45% (P < 0.05) in the remaining 6 patients with non-specific cardiomyopathy, compared with 24% in control specimens obtained from right ventricular muscle resected at surgery for tetralogy of Fallot. VCAM-1 was also present on 50% (P < 0.05) of the samples from the 5 patients with acute myocarditis, but was not present in those with non-specific cardiomyopathy. CONCLUSION: This persistent expression of ICAM-1 suggests that myocardial cell damage may persist immunologically for a long period in myocarditis. In addition, immunostaining for these adhesion molecules may be diagnostic value in clinically silent lymphocytic myocarditis and chronic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
T Ino (1997) conducted an observational in Lymphocytic myocarditis and cardiomyopathy (n=11). Acute myocarditis vs. Control specimens from right ventricular muscle resected for tetralogy of Fallot was evaluated on Expression of ICAM-1 on myocardial tissue (p=<0.01). Pediatric patients with healing-stage acute myocarditis had higher ICAM-1 expression on myocardial tissue compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: